CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.

CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

Lawmakers determined to enact new restrictions on pharmacy benefit managers are trying to include legislation, which nearly passed in December, in a budget package that must pass by next month.

Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Shares were up after the ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

Diagnosed with asthma as a baby, Cole Schmidtknecht took the inhaler daily as a preventive medication since he was about 13, ...

Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.

The U.S. Department of Labor alleged wrongful denials for ER and urinary drug screening; Eden Prairie-based company says processes are no longer in place.

REUTERS/Abubaker Lubowa/File Photo The number of confirmed Ebola cases in Uganda has risen to nine from three, the country's health ministry said.